ALEXANDRIA, Va., Feb. 12 -- United States Patent no. 12,222,356, issued on Feb. 11, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).
"Cytokine profiling analysis" was invented by Benedetto Farsaci (Princeton, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to methods for predicting a prognosis of a patient with cancer in need of an anti-cancer treatment comprising measuring a cytokine score from a sample obtained from the patient. In some embodiments, the subject is administered an anti-cancer treatment, e.g., an anti-PD-1 antibody, following the cytokine score measurement. In some embodiments, the cancer is lung cancer."
The patent was filed on Nov. 19, 2021, under App...